Novel discoveries in treatment may help children with ADHD
The CDC and National Institute of Mental Health have previously reported that the prevalence of neurodevelopmental disorders in children and adolescents has increased over the past several decades. The likely continued increase in diagnoses has led physicians and researchers to analyze the risks and benefits associated with current treatment options.
The editors of Infectious Diseases in Children have compiled an interactive online supplement highlighting the most recent study results available on children and adolescents with attention-deficit/hyperactivity disorder, including recent research that identified the combination of d-methylphenidate and guanfacine was more effective for the treatment of ADHD than either therapy alone.
In addition, results of a recent cross-sectional analysis of college students who did and did not misuse stimulants demonstrated that students who misused prescription stimulants were more likely to have conduct disorders as well as substance use disorder.